These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 1688087)

  • 61. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vaccine adjuvant uses of poly-IC and derivatives.
    Martins KA; Bavari S; Salazar AM
    Expert Rev Vaccines; 2015 Mar; 14(3):447-59. PubMed ID: 25308798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interferon-alpha produces significant decreases in HIV load.
    Tavel JA; Huang CY; Shen J; Metcalf JA; Dewar R; Shah A; Vasudevachari MB; Follmann DA; Herpin B; Davey RT; Polis MA; Kovacs J; Masur H; Lane HC
    J Interferon Cytokine Res; 2010 Jul; 30(7):461-4. PubMed ID: 20235638
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells.
    McKiel V; Gu Z; Wainberg MA; Hiscott J
    J Interferon Cytokine Res; 1995 Oct; 15(10):849-55. PubMed ID: 8564706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assay.
    Strayer DR; Watson P; Carter WA; Brodsky I
    J Interferon Res; 1986 Aug; 6(4):373-9. PubMed ID: 3772178
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
    Meng TC; Fischl MA; Boota AM; Spector SA; Bennett D; Bassiakos Y; Lai SH; Wright B; Richman DD
    Ann Intern Med; 1992 Jan; 116(1):13-20. PubMed ID: 1345755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
    Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O
    J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Action of drugs based on native DNA against RNA and DNA containing viruses].
    Vaĭnberg IP; Nosik DN; Kaplina EN; Nosik NN; Kalnina LB; Lavrukhina LA
    Klin Med (Mosk); 1995; 73(6):3-5. PubMed ID: 8691775
    [No Abstract]   [Full Text] [Related]  

  • 69. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.
    Saag MS; Emini EA; Laskin OL; Douglas J; Lapidus WI; Schleif WA; Whitley RJ; Hildebrand C; Byrnes VW; Kappes JC
    N Engl J Med; 1993 Oct; 329(15):1065-72. PubMed ID: 7690462
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mathematical modelling of chemotherapy in HIV infection.
    Hraba T; Dolezal J
    Folia Biol (Praha); 1994; 40(3):103-11. PubMed ID: 7805931
    [TBL] [Abstract][Full Text] [Related]  

  • 71. AZT blocks down-regulation of IL-2 and IFN-gamma gene expression in HIV acutely infected cells.
    Fan J; Li P; Kok TW; Burrell CJ
    Arch Virol; 1997; 142(5):1035-43. PubMed ID: 9191868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
    Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
    Bourinbaiar AS; Lee-Huang S; Krasinski K; Borkowsky W
    Biomed Pharmacother; 1994; 48(2):55-61. PubMed ID: 7919106
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease.
    Gottlieb AA; Sizemore RC; Gottlieb MS; Kern CH
    Biotherapy; 1996; 9(1-3):27-31. PubMed ID: 8993754
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Specific RNA drug therapy of hepatitis viruses.
    Carter WA; Suhadolnik RJ; Müller WE; Korba BE; Hubbell HR; Garcia G; Strayer DR
    Ann N Y Acad Sci; 1993 Jun; 685(1):758-61. PubMed ID: 8363282
    [No Abstract]   [Full Text] [Related]  

  • 79. A screening model of anti-HIV non AZT cross resistance virostatics.
    Mathé G; Pontiggia P
    Biomed Pharmacother; 1993; 47(10):461-2. PubMed ID: 8061247
    [No Abstract]   [Full Text] [Related]  

  • 80. A study of some tumours of human origin. II. Chromosome and late replication analysis of parental tumours, metastasis and ascites of the HR 18 rat tumour.
    Popescu NC; Cioloca L; Olăianos E
    Eur J Cancer (1965); 1970 Jun; 6(3):181-5. PubMed ID: 5477975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.